Other studies have also found that the CTLA-4 level of CD4+ T cells was negatively correlated with the disease activity and severity of SLE [40] and that immune rheostat dysregulation in SLE led to abnormal immune regulatory responses, resulting in reduced CTLA-4 expression in CD4+ T cells [49]. This evidence concerns the gene CTLA4 and systemic lupus erythematosus.